找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Data Monitoring in Clinical Trials; A Case Studies Appro David L. DeMets,Curt D. Furberg,Lawrence M. Friedm Book 2006 Springer-Verlag New Y

[復(fù)制鏈接]
樓主: hexagon
31#
發(fā)表于 2025-3-27 00:57:52 | 只看該作者
The Essentials of Nursing Management Seriesomparing candesartan with placebo in patients with chronic heart failure (CHF) who (1) were intolerant to angiotensin converting enzyme (ACE)-inhibitor and had left ventricular ejection fraction (LVEF) ≤ 40%, (2)) were on ACE-inhibitor and had LVEF ≤ 40% or (3)) had LVEF > 40%. CHARM provides an int
32#
發(fā)表于 2025-3-27 04:04:50 | 只看該作者
The Essentials of Nursing Management Seriesmplex process. It may involve, among other things, the need to (1) determine whether the observed treatment differences are likely to represent real effects and are not due to chance; (2) weigh the importance of different response variables, some possibly trending in favor of the treatment and some
33#
發(fā)表于 2025-3-27 08:06:37 | 只看該作者
The Patient-Surgeon Relationships with a recent myocardial infarction would reduce the incidence of sudden death and total mortality, using three drugs known to suppress cardiac arrhythmias. Patients were randomized to receive either active drug or a matching placebo. The trial was terminated after only 15% of the planned-for even
34#
發(fā)表于 2025-3-27 10:48:31 | 只看該作者
Communication with Young Peoplestudies with milrinone, a cyclic AMP-enhancing positive inotropic agent. Earlier studies had shown positive effects of milrinone on cardiac function and exercise performance in patients with chronic heart failure. To determine the effect of milrinone on mortality, patients with severe chronic heart
35#
發(fā)表于 2025-3-27 14:22:27 | 只看該作者
36#
發(fā)表于 2025-3-27 21:09:37 | 只看該作者
37#
發(fā)表于 2025-3-27 21:58:32 | 只看該作者
38#
發(fā)表于 2025-3-28 02:15:53 | 只看該作者
The Patient-Surgeon Relationshipythmias. Patients were randomized to receive either active drug or a matching placebo. The trial was terminated after only 15% of the planned-for events had been observed with an unexpected but dramatic increase in sudden death and total mortality in those patients receiving two of the active therapies. Later, the third drug was also discontinued.
39#
發(fā)表于 2025-3-28 10:04:55 | 只看該作者
40#
發(fā)表于 2025-3-28 13:23:52 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-31 04:20
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
彭泽县| 岚皋县| 通山县| 泸溪县| 务川| 通山县| 福海县| 扎囊县| 江源县| 南阳市| 区。| 凭祥市| 海伦市| 扎鲁特旗| 乌苏市| 琼结县| 休宁县| 黄大仙区| 西林县| 岑巩县| 肥乡县| 梧州市| 龙胜| 安阳市| 思南县| 侯马市| 新邵县| 白银市| 新干县| 拉孜县| 乐至县| 昭通市| 昌江| 天气| 金溪县| 施秉县| 舞钢市| 鄢陵县| 神农架林区| 罗源县| 大方县|